Buy & Sell Verisign, Inc. (VRSN) – Verisign, Inc. Price Today
First patient dosed in Phase 1b trial of Sapu003, an IV everolimus for advanced mTOR-sensitive tumors
Sapu Nano and Oncotelic have dosed the first patient in a Phase 1b clinical trial of Sapu003, an intravenous formulation of everolimus designed to treat advanced mTOR-sensitive solid tumors such as HR+/HER2- breast cancer and renal cell carcinoma. Th...
Cerebras Systems leads TSG Venture 50's first IPO, raising up to $4.8B in a major AI chip market debut
Cerebras Systems, an AI chip maker known for its wafer-scale engine technology, is set to debut on Nasdaq under ticker CBRS, marking the first IPO from TSG Invest's Venture 50 Index. The company raised its IPO price range to $150-$160 per share due t...
Techstars partners with Xendoo and Xero to provide startups with advanced financial tools from day one.
Techstars has formed a strategic partnership with fintech platform Xendoo and accounting software Xero to offer startups a comprehensive financial operations solution. This collaboration aims to help early-stage companies maintain better financial vi...
NevGold upsizes financing to C$42M, advancing US antimony-gold project with near-term production plans.
NevGold Corp. has increased its brokered private placement financing from C$25 million to over C$42 million due to strong institutional demand. The Vancouver-based junior miner is developing the Limousine Butte gold-antimony project in Nevada, target...
Quantum Cyber secures exclusive drone tech license amid $55B US drone warfare budget boost
Quantum Cyber has secured an exclusive license for BP United's autonomous drone technology, including a sky defense platform capable of over 25 km range and fully autonomous operations. This move positions Quantum Cyber to capitalize on the Trump adm...
Corbus Pharmaceuticals to present at RBC and Jefferies healthcare conferences in May and June 2026
Corbus Pharmaceuticals Holdings, a clinical-stage biotech company focused on oncology and obesity therapies, announced CEO Yuval Cohen will present corporate updates and meet investors at two major healthcare conferences in New York: the RBC Capital ...
Charter CFO to speak at J.P. Morgan tech conference May 20, webcast available
Charter Communications announced that its Chief Financial Officer, Jessica Fischer, will speak at the J.P. Morgan Global Technology, Media and Communications Conference on May 20, 2026, in Boston. Her remarks will start at 8:00 a.m. ET and will be av...
SPARC AI establishes permanent Ukraine base to boost Overwatch drone software integration.
SPARC AI Inc. is setting up a permanent subsidiary in Ukraine to accelerate the adoption of its Overwatch autonomous mission software among Ukrainian drone manufacturers and operators. This move aims to unify different drone fleets into a single oper...
Harrow's stock drops 23.7% after revenue miss and securities law probe announced
Harrow, Inc. reported first-quarter 2026 revenue for its VEVYE product at $20.9 million, below expectations due to an $8 million gross-to-net reduction linked to new commercial coverage. Following this announcement, Harrow's stock price fell 23.69% o...
PharmaTher's Sairiyo advances oral Cepharanthine to treat Hantavirus, showing strong antiviral potential in preclinical studies.
PharmaTher Holdings' affiliate Sairiyo Therapeutics is developing PD-001, an oral enteric-coated form of Cepharanthine, as a potential treatment for Hantavirus infections. Independent research shows Cepharanthine inhibits Hantavirus entry and infecti...